Ginkgo folii extractum siccum
This medicine should always be taken exactly as described in the patient leaflet or according to the doctor's or pharmacist's instructions.
Tanakan is used to improve impaired cognitive functions in older people and to improve the quality of life of patients with mild dementia.
If the patient is allergic to the extract of Ginkgo biloba leaves or to any of the other ingredients of this medicine (listed in section 6).
In case of doubts related to the use of the medicine, you should consult a doctor or pharmacist.
Before starting to take Tanakan, you should consult a doctor or pharmacist.
The medicine is not intended for children and adolescents under 18 years of age.
You should tell your doctor or pharmacist about all medicines that the patient is currently taking or has recently taken, as well as about medicines that the patient plans to take.
Tanakan may affect the way other medicines work. Examples of medicines that Tanakan may affect:
Note that the above list is not exhaustive.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult a doctor before taking this medicine.
As a precaution, the use of Tanakan should be avoided during pregnancy or breastfeeding.
Some people may experience dizziness after taking Tanakan. If this happens, you should not drive or operate machines.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free).
This medicine should always be taken according to the doctor's instructions. In case of doubts, you should consult a doctor or pharmacist.
Adults: The recommended dose is three tablets a day, evenly distributed throughout the day.
Orally.
Tablets should be taken during meals, with ½ glass of water.
According to the doctor's instructions.
There is no significant experience with overdose of Tanakan.
You should not take a double dose to make up for a missed dose.
Like all medicines, Tanakan can cause side effects, although not everybody gets them.
Summary of safety profile
The most common side effects reported are: abdominal pain, diarrhea, and dizziness.
If the patient experiences a severe allergic reaction (angioedema) causing swelling of the face, lips, tongue, or throat, you should stop taking the medicine and seek immediate medical attention.
Other side effects:
Common: (occurring in no more than 1 in 10 people)
o Allergic reactions
o Breathing difficulties
o Headache
o Fainting
o Nausea
o Malaise
o Eczema (skin rash)
o Itching
Uncommon: (occurring in no more than 1 in 100 people)
o Hives
o Rash
If you experience any side effects, including any possible side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
Store in a temperature below 25°C. Store in the original packaging to protect from light and moisture.
Medicines should not be disposed of via wastewater or household waste containers. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is dry extract of Ginkgo biloba leaves (Ginkgo folii extractum siccum). Each coated tablet contains 40 mg of dry extract of Ginkgo biloba, purified and quantified (EGb 761) from Ginkgo biloba L., folium(Ginkgo biloba leaf) (DER 35-67:1), including: 24% ginkgo flavonoid glycosides and 6% ginkgolides and bilobalide.
Extractant: 60% acetone (w/w).
Other ingredients are:
Microcrystalline cellulose
Sodium croscarmellose
Magnesium stearate
Coating:
Polyethylene glycol 6000
Hypromellose
Iron oxide red
The package contains 30 or 90 coated tablets (15 coated tablets in an Al/PVC blister pack).
To obtain more detailed information, you should contact the marketing authorization holder or the parallel importer.
IPSEN Consumer HealthCare
65 quai Georges Gorse
92100 Boulogne-Billancourt
France
Beaufour Ipsen Industrie
Dreux
France
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Pharma Innovations Sp. z o.o.
ul. Jagiellońska 76
03-301 Warsaw
Laboratorium Galenowe Olsztyn Sp. z o.o.
ul. Spółdzielcza 25A
11-001 Dywity
Synoptis Industrial Sp. z o.o.
ul. Szosa Bydgoska 58
87-100 Toruń
Marketing authorization number in the Czech Republic, the country of export: 94/877/92-C
Parallel import authorization number: 274/19
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.